4521.T
Price:
$3789
Market Cap:
$138.69B
Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. It offers pharmaceutical products and medical devices, such as Clenafin, a topical treatment for onychomycosis; Artz, an anti-osteoarthritis agent; Seprafilm, a semitransparent film-type absorbable adhesion barrier, which is applied to damaged tissue; Fiblast, a spray-on drug for the treatment of pressure ulcers and other skin ulcers; Regroth, a medicinal product for periodontal regeneration; and Hernicore for the treatment of lumbar disc herniation. The company also provides Adofeed, a pain- and inflammation-relieving plaster; Ebrantil for the treatm...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2001-01-01
Stock Exchange
JPX
Ticker
4521.T
According to Kaken Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 9.22%. This represents a change of 306.75% compared to the average of 2.27% of the last 4 quarters.
The mean historical ROE of Kaken Pharmaceutical Co., Ltd. over the last ten years is 12.69%. The current 9.22% ROE has changed -27.34% with respect to the historical average. Over the past ten years (40 quarters), 4521.T's ROE was at its highest in in the December 2015 quarter at 8.30%. The ROE was at its lowest in in the March 2025 quarter at -3.43%.
Average
12.69%
Median
12.26%
Minimum
3.99%
Maximum
23.53%
Discovering the peaks and valleys of Kaken Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 63.66%
Maximum Annual ROE = 23.53%
Minimum Annual Increase = -42.41%
Minimum Annual ROE = 3.99%
Year | ROE | Change |
---|---|---|
2025 | 9.14% | 63.66% |
2024 | 5.58% | 39.82% |
2023 | 3.99% | -42.41% |
2022 | 6.93% | -29.54% |
2021 | 9.84% | -34.75% |
2020 | 15.08% | 2.75% |
2019 | 14.67% | -12.25% |
2018 | 16.72% | -22.03% |
2017 | 21.45% | -8.83% |
2016 | 23.53% | 49.62% |
The current ROE of Kaken Pharmaceutical Co., Ltd. (4521.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.24%
5-year avg
7.10%
10-year avg
12.69%
Kaken Pharmaceutical Co., Ltd.’s ROE is less than Tsumura & Co. (11.10%), less than Nippon Shinyaku Co., Ltd. (13.61%), less than Sumitomo Pharma Co., Ltd. (15.48%), less than Shionogi & Co., Ltd. (12.93%), less than Hisamitsu Pharmaceutical Co., Inc. (8.10%),
Company | ROE | Market cap |
---|---|---|
11.10% | $271.59B | |
13.61% | $202.47B | |
15.48% | $410.00B | |
12.93% | $2.12T | |
8.10% | $285.87B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kaken Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kaken Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Kaken Pharmaceutical Co., Ltd.'s ROE?
How is the ROE calculated for Kaken Pharmaceutical Co., Ltd. (4521.T)?
What is the highest ROE for Kaken Pharmaceutical Co., Ltd. (4521.T)?
What is the 3-year average ROE for Kaken Pharmaceutical Co., Ltd. (4521.T)?
What is the 5-year average ROE for Kaken Pharmaceutical Co., Ltd. (4521.T)?
How does the current ROE for Kaken Pharmaceutical Co., Ltd. (4521.T) compare to its historical average?